NCT03133325View on ClinicalTrials.gov

A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

July 13, 2017

Study Completion Date

July 13, 2017

Conditions
Safety
Interventions
DEVICE

GP0045

Hyaluronic acid gel

DEVICE

Restylane Lyft Lidocaine

Hyaluronic acid gel

Trial Locations (1)

Unknown

CTC, Uppsala

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03133325 - A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine | Biotech Hunter | Biotech Hunter